Skip to main content

Table 4 Meta-regressiosn analysis of the biochemical cure rate and recurrence rate of DAs and surgery

From: Are dopamine agonists still the first-choice treatment for prolactinoma in the era of endoscopy? A systematic review and meta-analysis

 

Biochemical cure rate

Recurrence rate

Surgery

DAs

Surgery

DAs

Gender

0.019

0.601

0.479

NAa

Year

0.154

0.103

0.479

NAa

Age

0.065

0.495

0.999

0.313

Microprolactinoma

0.880

0.578

0.350

0.732

Macroprolactinoma

0.001

0.235

0.068

0.836

Giant prolactinoma

0.482

0.029

NAa

NAa

Microscopic surgery

0.843

NAb

NAa

NAb

Endoscopic surgery

0.199

NAb

0.773

NAb

Bromocriptine

NAb

0.024

NAb

0.248

Cabergoline

NAb

0.935

NAb

0.520

  1. Das dopamine agonists, NAa not applicable, because the data was not provided by included studies or enough to be included in the meta-regression analysis. NAb not applicable, because the data was not discussed or calculated in the meta-analysis